These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23469146)

  • 1. The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells.
    Lin C; Lu W; Zhang W; Londoño-Joshi AI; Buchsbaum DJ; Bu G; Li Y
    PLoS One; 2013; 8(2):e58102. PubMed ID: 23469146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesd is a universal inhibitor of Wnt coreceptors LRP5 and LRP6 and blocks Wnt/beta-catenin signaling in cancer cells.
    Lu W; Liu CC; Thottassery JV; Bu G; Li Y
    Biochemistry; 2010 Jun; 49(22):4635-43. PubMed ID: 20446724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesd is a general inhibitor of different Wnt ligands in Wnt/LRP signaling and inhibits PC-3 tumor growth in vivo.
    Lin C; Lu W; Zhai L; Bethea T; Berry K; Qu Z; Waud WR; Li Y
    FEBS Lett; 2011 Oct; 585(19):3120-5. PubMed ID: 21907199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of LRP5/6-mediated Wnt/β-catenin signaling by Mesd attenuates hyperoxia-induced pulmonary hypertension in neonatal rats.
    Alapati D; Rong M; Chen S; Lin C; Li Y; Wu S
    Pediatr Res; 2013 Jun; 73(6):719-25. PubMed ID: 23481549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding.
    Li Y; Chen J; Lu W; McCormick LM; Wang J; Bu G
    J Cell Sci; 2005 Nov; 118(Pt 22):5305-14. PubMed ID: 16263759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting molecular differences between Wnt coreceptors LRP5 and LRP6.
    MacDonald BT; Semenov MV; Huang H; He X
    PLoS One; 2011; 6(8):e23537. PubMed ID: 21887268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
    Ring L; Neth P; Weber C; Steffens S; Faussner A
    Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
    Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
    PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells.
    Fenderico N; van Scherpenzeel RC; Goldflam M; Proverbio D; Jordens I; Kralj T; Stryeck S; Bass TZ; Hermans G; Ullman C; Aastrup T; Gros P; Maurice MM
    Nat Commun; 2019 Jan; 10(1):365. PubMed ID: 30664649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal-Recessive Mutations in MESD Cause Osteogenesis Imperfecta.
    Moosa S; Yamamoto GL; Garbes L; Keupp K; Beleza-Meireles A; Moreno CA; Valadares ER; de Sousa SB; Maia S; Saraiva J; Honjo RS; Kim CA; Cabral de Menezes H; Lausch E; Lorini PV; Lamounier A; Carniero TCB; Giunta C; Rohrbach M; Janner M; Semler O; Beleggia F; Li Y; Yigit G; Reintjes N; Altmüller J; Nürnberg P; Cavalcanti DP; Zabel B; Warman ML; Bertola DR; Wollnik B; Netzer C
    Am J Hum Genet; 2019 Oct; 105(4):836-843. PubMed ID: 31564437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors.
    Nagaoka T; Karasawa H; Turbyville T; Rangel MC; Castro NP; Gonzales M; Baker A; Seno M; Lockett S; Greer YE; Rubin JS; Salomon DS; Bianco C
    Cell Signal; 2013 Jan; 25(1):178-89. PubMed ID: 23022962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of LRP6-mediated Wnt signaling by molecular chaperone Mesd.
    Li Y; Lu W; He X; Bu G
    FEBS Lett; 2006 Oct; 580(22):5423-8. PubMed ID: 16989816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.
    Lu W; Lin C; King TD; Chen H; Reynolds RC; Li Y
    Cell Signal; 2012 Dec; 24(12):2291-6. PubMed ID: 22820499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of a frizzled8.Wnt3a.LRP6 signaling complex reveals multiple Wnt and Dkk1 binding sites on LRP6.
    Bourhis E; Tam C; Franke Y; Bazan JF; Ernst J; Hwang J; Costa M; Cochran AG; Hannoush RN
    J Biol Chem; 2010 Mar; 285(12):9172-9. PubMed ID: 20093360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRP6 dimerization through its LDLR domain is required for robust canonical Wnt pathway activation.
    Chen J; Yan H; Ren DN; Yin Y; Li Z; He Q; Wo D; Ho MS; Chen Y; Liu Z; Yang J; Liu S; Zhu W
    Cell Signal; 2014 May; 26(5):1068-74. PubMed ID: 24412751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt co-receptor LRP5/6 overexpression confers protection against hydrogen peroxide-induced neurotoxicity and reduces tau phosphorylation in SH-SY5Y cells.
    Zhang L; Bahety P; Ee PL
    Neurochem Int; 2015 Aug; 87():13-21. PubMed ID: 25959626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
    Peröbner I; Karow M; Jochum M; Neth P
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-based mediated disruption of N-cadherin-LRP5/6 interaction promotes Wnt signaling and bone formation.
    Haÿ E; Buczkowski T; Marty C; Da Nascimento S; Sonnet P; Marie PJ
    J Bone Miner Res; 2012 Sep; 27(9):1852-63. PubMed ID: 22576936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative folding and ligand-binding properties of LRP6 beta-propeller domains.
    Liu CC; Pearson C; Bu G
    J Biol Chem; 2009 May; 284(22):15299-307. PubMed ID: 19339249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAP1 Regulates Wnt/β-Catenin Pathway through LRP5/6 Receptors Expression Modulation.
    Lettini G; Condelli V; Pietrafesa M; Crispo F; Zoppoli P; Maddalena F; Laurenzana I; Sgambato A; Esposito F; Landriscina M
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33065966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.